Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > $500 million for 10%...
View:
Post by riverrrow on Sep 09, 2023 8:47am

$500 million for 10%...

...of the company.  I'ld be willing to accept that offer.  Now I just need to find somebody who will make that offer.
Comment by Oilminerdeluxe on Sep 09, 2023 9:13am
Same here. 10%, fine by me. I am quite puzzled by the recent pp.  It's like 2 months of burn rate, tops. In a perfect world that could mean they have sent in the BTD application and the money is meant to last until a decision arrrives. Then make a much bigger raise, or a j/v, if the company receives it. Sounds sweet and dandy. But this is TLT, hardly anything has gone smoothly these past ...more  
Comment by Legit62 on Sep 09, 2023 9:54am
My question is do we receive AA with BTD cause our data and safety is so good and will that allow us to get paid going foward?? Or is our JV partner telling Roger you are all set once TLT gets BTD. We will find out shortly, 
Comment by Longholder99 on Sep 09, 2023 11:03am
Could be that this player has been along for the ride the whole time.  Has participated in the PPs etc. maybe?   Roger is possibly just being loyal and the partner is being distant out of respect for RW wanting to follow his plan.  May explain his obvious confidence at all AGMs and the quiet running in terms of promotion of the company and process/molecule.  
Comment by 99942Apophis on Sep 09, 2023 12:32pm
I am not picking on you Legit62 however I strongly feel Theralase has more than 1 JV partnerships in mind for commercialization!  Although I do agree with your thought of one or more entering the partnership with a small cash infusion for ownership percentage. Interesting that discussion here is again in hypothesis mode.
Comment by Legit62 on Sep 09, 2023 12:45pm
exactly, that was what my thinking was, or we are up shits creek and we cant raise cash which i dont believe. i think he raised what he needed to
Comment by patience69 on Sep 09, 2023 12:54pm
IMO he raised as much as he could under the current circumstances. I am willing to wager that most people are tapped out & have done their share. I could be wrong but I cant see the effort for less than 500k frankly. This was a continuation of the last pp which was up to 5M. It only raised 1.2 so I bet hopes were to get closer to the 5. Being a glass half full person I sort of think that maybe ...more  
Comment by Beano349 on Sep 09, 2023 11:30am
In the last release, they had received feedback on BTD from the FDA and were resubmitted a preapplication soon...and if that goes well submitting a formal application. They thought Q4 or Q1 to hear back. I would consider this good news as they are working with the FDA and accepting whatever criticism now and fixing it. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250